PNTG

NEUTRALEarnings

The Pennant Group, Inc.

2026-10-28

Price

$42.16

+1.64%

This is the 2026-10-28 snapshot — the signals and analysis for PNTG as of this single trading day.

View full PNTG research hub →

Score11.0Priority

Signals5/8 DNA2/13 Act · 1/4 Risk

SentimentNEUTRALScore: 8

Volume1.3xvs 20d avg

Analysis

PNTG's breakout to fresh 52-week highs represents High-Conviction Price Discovery, driven by a 35% year-over-year revenue surge and upward analyst revisions. The stock's PERFECT_STACK and QUIET_ACCUMULATION signals align perfectly with real-time news of strategic real estate acquisitions and defensive resilience amid recent geopolitical market jitters. Operating in a RISK_ON (EARNINGS) macro regime with exceptionally tight credit spreads, institutional buyers are confidently absorbing valuation concerns, aggressively bidding up this healthcare growth story ahead of its upcoming Q3 report.

Fired Signals

ALPHA MALESTEADY CLIMBGOLDEN CROSSMARKET LEADERPERFECT STACKQUIET ACCUMULATIONINSIDE OUTWEAK FINISH

Key Takeaways

Actionable Thesis: Ride the institutional momentum and STEADY_CLIMB signals toward the $46-$48 analyst target range, as PNTG demonstrates defensive resilience and top-line growth.
Key Risk: A premium valuation of ~46x trailing P/E and ~6x net debt/EBITDA leaves the stock highly vulnerable to any earnings misses or margin compression.
What to Watch: Monitor the upcoming Q3 earnings release in early November and ensure price holds above the $36.76 structural support level to maintain the bullish thesis.

← Back to 2026-10-28 View Full PNTG History →Yahoo Finance &nearr;